Most Read Articles
Pearl Toh, 06 Sep 2016
Incidence of early-stage prostate cancer in the US has continued to decrease from 2012 to 2013, following recommendation against screening for prostate specific antigen (PSA) by the US Preventive Services Task Force (USPSTF) in 2012, reported researchers of the American Cancer Society.
Jackey Suen, 30 Jan 2019

Recent research has revealed various potential biomarkers for metastatic castration-resistant prostate cancer (mCRPC), but several challenges remain in fully utilizing them in clinical practice.

5 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

Christina Lau, 02 May 2019
Verubecestat, an investigational beta-site amyloid precursor protein–cleaving enzyme 1 (BACE-1) inhibitor that blocks the production of amyloid-beta, does not improve cognition or daily function in patients with prodromal Alzheimer’s disease, results of a new study have shown.

Premier Gathering of MedTech Experts to Explore Technology for the Future of Healthcare

13 Sep 2018
The Asia Pacific Medical Technology Association (APACMed), the regional trade association for the medical devices and in vitro diagnostics industry, will host its fourth annual Asia Pacific MedTech Forum from 9-11 October 2018 at the Suntec International Convention & Exhibition Centre in Singapore.

Over 600 senior leaders in the healthcare sector, including global and regional leaders of medical device manufacturers, healthcare providers, policy-makers, regulators, government representatives, clinicians,startups and SMEs, are expected to attend the Forum.

Under the theme “Technology in Healthcare: Empowering Patients; Driving Outcomes”, a range of high profile speakers will address how advancements in medical and digital technologies are impacting healthcaredelivery in Asia Pacific.

“The healthcare industry is advancing at a rapid pace in Asia Pacific and its convergence with the digital scene is proving a major engine of growth, with new life changing technologies emerging in the industry. This year’s Asia Pacific MedTech Forum focuses on technology as an enabler and the impact on patient outcomes. Experts will come together to share their insights on the latest innovations and discuss the future of the MedTech sector”, said Fredrik Nyberg, Chief Executive Officer, APACMed.

The Forum will feature curated education sessions, technology demonstrations, exhibits and networking. This year’s line-up of expert speakers includes:
  • Kevin A. Lobo, Chairman and Chief Executive Officer, Stryker
  • Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson
  • Dr Zoran Bolevich, Chief Executive and Chief Information Officer, eHealth NSW
  • Kyu Rhee, Vice President and Chief Health Officer at IBM Corporation and IBM Watson Health, will discuss the advancements of AI in healthcare
Additional distinguished healthcare providers and NGOs include Caroline Riady, Managing Director of Siloam Hospitals, Gautam Khanna, Chief Executive Officer of P.D. Hinduja Hospital & MRC, and Dr Natasha Reyes, Director of Operational Support Unit and Interim Executive Director Medecins Sans Frontières and DoctorsWithout Borders (Hong Kong).

For more information, including the full programme, speaker list, and registration details, please visit https://www.medtechforum.asia.

Media interested in attending the event or interviewing speakers should contact apacmed@spurwingcomms.com.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Singapore digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 06 Sep 2016
Incidence of early-stage prostate cancer in the US has continued to decrease from 2012 to 2013, following recommendation against screening for prostate specific antigen (PSA) by the US Preventive Services Task Force (USPSTF) in 2012, reported researchers of the American Cancer Society.
Jackey Suen, 30 Jan 2019

Recent research has revealed various potential biomarkers for metastatic castration-resistant prostate cancer (mCRPC), but several challenges remain in fully utilizing them in clinical practice.

5 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

Christina Lau, 02 May 2019
Verubecestat, an investigational beta-site amyloid precursor protein–cleaving enzyme 1 (BACE-1) inhibitor that blocks the production of amyloid-beta, does not improve cognition or daily function in patients with prodromal Alzheimer’s disease, results of a new study have shown.